Ultralife (ULBI)
(Delayed Data from NSDQ)
$9.61 USD
+0.09 (0.95%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.62 +0.01 (0.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Ultralife Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10 | 6 | 8 | 11 | 7 |
Receivables | 32 | 28 | 20 | 21 | 30 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 42 | 41 | 33 | 28 | 30 |
Other Current Assets | 6 | 4 | 5 | 5 | 3 |
Total Current Assets | 90 | 79 | 67 | 65 | 70 |
Net Property & Equipment | 21 | 22 | 23 | 23 | 23 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 11 | 12 | 11 | 12 | 13 |
Intangibles | 53 | 53 | 55 | 36 | 36 |
Deposits & Other Assets | 4 | 2 | 3 | 2 | 2 |
Total Assets | 178 | 168 | 160 | 138 | 145 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 11 | 16 | 10 | 11 | 9 |
Current Portion Long-Term Debt | 2 | 2 | 2 | 1 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 11 | 7 | 7 | 6 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 24 | 29 | 19 | 19 | 17 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 1 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 24 | 19 | 19 | 0 | 16 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 2 | 2 | 2 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 53 | 52 | 42 | 21 | 35 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 189 | 187 | 187 | 185 | 184 |
Retained Earnings | -41 | -48 | -48 | -48 | -53 |
Other Equity | -4 | -4 | -2 | -2 | -3 |
Treasury Stock | 21 | 21 | 21 | 21 | 21 |
Total Shareholder's Equity | 125 | 116 | 118 | 117 | 110 |
Total Liabilities & Shareholder's Equity | 178 | 168 | 160 | 138 | 145 |
Total Common Equity | 125 | 116 | 118 | 117 | 110 |
Shares Outstanding | 16.30 | 16.10 | 16.00 | 15.90 | 15.80 |
Book Value Per Share | 7.70 | 7.23 | 7.36 | 7.35 | 6.95 |
Fiscal Year End for Ultralife Corporation falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7 | 10 | 10 | 9 | 8 |
Receivables | 31 | 35 | 32 | 27 | 29 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 41 | 44 | 42 | 47 | 46 |
Other Current Assets | 5 | 5 | 6 | 6 | 5 |
Total Current Assets | 84 | 94 | 90 | 90 | 88 |
Net Property & Equipment | 20 | 21 | 21 | 21 | 21 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 9 | 10 | 11 | 11 | 11 |
Intangibles | 52 | 52 | 53 | 53 | 53 |
Deposits & Other Assets | 5 | 3 | 4 | 2 | 2 |
Total Assets | 170 | 181 | 178 | 176 | 175 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 10 | 13 | 11 | 13 | 19 |
Current Portion Long-Term Debt | 2 | 2 | 2 | 2 | 2 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 8 | 10 | 11 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 21 | 23 | 24 | 26 | 29 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 2 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 10 | 23 | 24 | 24 | 23 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 4 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 36 | 52 | 53 | 54 | 56 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 191 | 190 | 189 | 189 | 188 |
Retained Earnings | -35 | -38 | -41 | -44 | -45 |
Other Equity | -4 | -4 | -4 | -4 | -4 |
Treasury Stock | 21 | 21 | 21 | 21 | 21 |
Total Shareholder's Equity | 133 | 129 | 125 | 122 | 120 |
Total Liabilities & Shareholder's Equity | 170 | 181 | 178 | 176 | 175 |
Total Common Equity | 133 | 129 | 125 | 122 | 120 |
Shares Outstanding | 16.60 | 16.40 | 16.30 | 16.30 | 16.10 |
Book Value Per Share | 8.03 | 7.86 | 7.70 | 7.47 | 7.43 |